Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets
Related Experiment Video
Updated: May 17, 2026

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
Published on: January 7, 2019
R Stachowiak1, M Lyzniak, B K Budziszewska
1Department of Applied Microbiology, University of Warsaw, 02-096 Warsaw, Poland.
Abstract:
Bacterial toxins can exhibit anticancer activities. Here we investigated the anticancer effects of the listeriolysin O toxin produced by Listeria monocytogenes. We found that supernatants of Listeria monocytogenes strains (wild type, 1189, and 1190) were cytotoxic to the Jurkat cell line and human peripheral blood mononuclear cells (PBMC) in a concentration-dependent manner. The supernatant of strain 1044, not producing listeriolysin O, was inactive. The supernatants of Listeria strains were also cytotoxic toward B cells of chronic leukemia patients, with no significant differences in activities between strains. We also tested supernatants of Bacillus subtilis strains BR1-90, BR1-S, and BR1-89 producing listeriolysin O. BR1-S and BR1-89 were cytotoxic to PBMC and to Jurkat cells, the latter being more sensitive to the supernatants. BR1-90 was not hemolytic or cytotoxic to PBMC, but was cytotoxic to Jurkat cells in the concentration range of 10-30%, suggesting that listeriolysin O is selectively effective against T cells. Overall, the response of human peripheral blood mononuclear and human leukemia cell lines to bacteria supernatants containing listeriolysin O depended on the bacteria strain, target cell type, and supernatant concentration.
Insights
Bacterial toxins like listeriolysin O show anticancer potential. This study found listeriolysin O from Listeria and Bacillus strains effectively reduced cancer cell viability, particularly T cells.
Area of Science:
- Microbiology
- Immunology
- Toxicology
Background:
- Bacterial toxins are increasingly recognized for their therapeutic potential, including anticancer activities.
- Listeriolysin O (LLO), a toxin from Listeria monocytogenes, is a pore-forming protein with immunomodulatory properties.
- Investigating LLO's cytotoxic effects on cancer cell lines is crucial for developing novel cancer therapies.
Purpose of the Study:
- To evaluate the anticancer effects of bacterial supernatants containing listeriolysin O.
- To determine the cytotoxicity of LLO from Listeria monocytogenes and Bacillus subtilis against various human cell lines.
- To assess the influence of bacterial strain, target cell type, and supernatant concentration on LLO's efficacy.
Main Methods:
- Cytotoxicity assays were performed using Jurkat cell line (T cell leukemia) and human peripheral blood mononuclear cells (PBMC).
- Supernatants from Listeria monocytogenes and Bacillus subtilis strains, with and without LLO production, were tested.
- The impact of varying supernatant concentrations on cell viability was analyzed.
Main Results:
- Supernatants from LLO-producing Listeria monocytogenes strains demonstrated concentration-dependent cytotoxicity against Jurkat cells and PBMC.
- Bacillus subtilis strains producing LLO also exhibited cytotoxicity towards PBMC and Jurkat cells, with Jurkat cells showing higher sensitivity.
- LLO-producing bacterial supernatants were cytotoxic to B cells from chronic leukemia patients, irrespective of the strain.
- One Bacillus subtilis strain lacking hemolytic activity showed selective cytotoxicity against Jurkat cells, suggesting LLO's specific effectiveness against T cells.
Conclusions:
- Listeriolysin O from both Listeria monocytogenes and Bacillus subtilis possesses significant anticancer activity against human leukemia and PBMC.
- The efficacy of LLO-containing supernatants is dependent on the specific bacterial strain, the type of target cell, and the concentration of the supernatant.
- LLO demonstrates selective cytotoxicity, particularly against T cell lines, highlighting its potential as a targeted anticancer agent.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Toxins
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Hypersensitivity Reactions: Cytolytic Reactions
Inhibitors of Bacterial Protein Synthesis

